Ads
related to: sickle cell anemia- Mechanism Of Action
Learn About The LYFGENIA
MOA & How It Works.
- FAQs
Get Answers To Questions
About Treatment With LYFGENIA.
- Safety Information
Review Information On Adverse
Reactions & Additional Safety Data.
- Request A Representative
Fill Out The Online Form To Be
Contacted About LYFGENIA.
- Mechanism Of Action
Search results
Results From The WOW.Com Content Network
Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. [3] It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anemia.
The underlying cause of sickle cell anemia is the synthesis of aberrant hemoglobin, which attaches to other aberrant hemoglobin molecules inside the red blood cell to undergo rigid deformation. [18] Sickle cell anemia symptoms usually appear around the age of six months. They can change over time and differ from person to person.
Poikilocytes may be oval, teardrop-shaped, sickle-shaped or irregularly contracted. Normal red blood cells are round, flattened disks that are thinner in the middle than at the edges. A poikilocyte is an abnormally-shaped red blood cell. [1]
The ESR is decreased in polycythemia, hyperviscosity, sickle cell anemia, leukemia, chronic fatigue syndrome, [4] low plasma protein (due to liver or kidney disease) and congestive heart failure. Although increases in immunoglobulins usually increase the ESR, very high levels can reduce it again due to hyperviscosity of the plasma. [5]
A complete blood count (CBC) may show increased reticulocytes, a sign of increased red blood cell production, and decreased hemoglobin and hematocrit. The term "non-hereditary spherocytosis" is occasionally used, albeit rarely. [2] Lists of causes: [3] Warm autoimmune hemolytic anemia; Cold autoimmune hemolytic anemia/paroxysmal cold hemoglobinuria
These accumulations may be caused by excessive red blood cell destruction (haemolysis), excessive iron uptake/hyperferraemia, or decreased iron utilization (e.g., anaemia of copper toxicity) uptake hypoferraemia (which often leads to iron deficiency anemia). Cellular iron is found as either ferritin or hemosiderin.